2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2645
  



  

  
Submitter : 
  

  
Ms. Sue Schweizer
  

  
Date & Time: 
  

  
12/06/2006 09:12:45
  



  

  
Organization : 
  

  
Ms. Sue Schweizer
  



  

  
Category : 
  

  
Drug Industry
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 [2006D0383] There are a number of cell lines which have originated from ethical and completely non-controversial sources for the development of vaccines. I support the FDA recommending that pharmaceutical companies use these cells from non-controversial sources instead of cells derived from aborted children.